Ketorolac-fluconazole: A New Combination Reverting Resistance in Candida albicans from Acute Myeloid Leukemia Patients on Induction Chemotherapy: In vitro Study

BACKGROUND AND OBJECTIVES: Candida albicans is a significant source of morbidity and mortality for patients with acute myeloid leukemia (AML). Prolonged use of fluconazole as empirical antifungal prophylaxis in AML patients leads to overexpression of efflux pump genes that resulted in the emergence...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayed, Shereen A, Hassan, Ehsan A B, Abdel Hameed, Muhamad R, Agban, Michael N, Mohammed Saleh, Mostafa F, Mohammed, Hayam H, Abdel-Aal, Abu-Baker M, Elgendy, Sherein G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214543/
https://www.ncbi.nlm.nih.gov/pubmed/34163275
http://dx.doi.org/10.2147/JBM.S302158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214543/
https://www.ncbi.nlm.nih.gov/pubmed/34163275
http://dx.doi.org/10.2147/JBM.S302158

Ejemplares similares